Fiche publication
Date publication
mai 2015
Journal
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Auteurs
Membres identifiés du Cancéropôle Est :
Dr CASASNOVAS Olivier
Tous les auteurs :
Kelly JL, Salles G, Goldman B, Fisher RI, Brice P, Press O, Casasnovas O, Maloney DG, Soubeyran P, Rimsza L, Haioun C, Xerri L, LeBlanc M, Tilly H, Friedberg JW
Lien Pubmed
Résumé
Recent literature reports a potential association between high vitamin D and improved lymphoma prognosis. We evaluated the impact of pretreatment vitamin D on follicular lymphoma (FL) outcome.
Mots clés
Antibodies, Monoclonal, administration & dosage, Antineoplastic Combined Chemotherapy Protocols, adverse effects, Biomarkers, blood, Chromatography, Liquid, Cyclophosphamide, administration & dosage, Disease Progression, Disease-Free Survival, Doxorubicin, administration & dosage, Female, Humans, Kaplan-Meier Estimate, Lymphoma, Follicular, blood, Male, Middle Aged, Prednisone, administration & dosage, Proportional Hazards Models, Prospective Studies, Risk Factors, Rituximab, administration & dosage, Tandem Mass Spectrometry, Time Factors, Treatment Outcome, Vincristine, administration & dosage, Vitamin D, analogs & derivatives, Vitamin D Deficiency, blood
Référence
J. Clin. Oncol.. 2015 May 1;33(13):1482-90
